|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||
| Net income (loss) | ||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||
| Equity-based compensation | ||||
| Net investment income | ||||
| Net recognized (gains) losses on investments and derivatives | ||||
| Depreciation and amortization | ||||
| Net amortization (accretion) of net investment premiums, discount and other | ||||
| Policy acquisition costs deferred | ||||
| Other non-cash amounts included in net income (loss), net | ||||
| Changes in consolidation | ||||
| Changes in operating assets and liabilities: | ||||
| Purchases of investments by funds and VIEs | ||||
| Proceeds from sale of investments by funds and VIEs | ||||
| Interest sensitive contract liabilities | ||||
| Future policy benefits, market risk benefits and reinsurance recoverable | ||||
| Other assets and liabilities, net | ||||
| Net cash provided by operating activities | ||||
| Cash Flows from Investing Activities | ||||
| Purchases of investments and contributions to equity method investments | ||||
| Purchases of available-for-sale securities | ||||
| Purchases of mortgage loans | ||||
| Purchases of investment funds | ||||
| Purchases of U.S. Treasury securities | ||||
| VIE, Primary Beneficiary | ||||
| Total purchases of U.S. Treasury securities | ||||
| Purchases of derivatives instruments and other investments | ||||
| Sales, maturities and repayments of investments and distributions from equity method investments | ||||
| Cash acquired through merger | ||||
| Acquisition of subsidiaries, net of cash acquired | ||||
| Other investing activities, net | ||||
| Net cash used in investing activities | ||||
| Cash Flows from Financing Activities | ||||
| Issuance of debt | ||||
| VIE, Primary Beneficiary | ||||
| Total issuance of debt | ||||
| Principal repayment of debt | ||||
| Repayment of debt | ||||
| Repurchase of common stock | ||||
| Common stock dividends | ||||
| Preferred stock dividends | ||||
| Distributions paid to non-controlling interests | ||||
| VIE, Primary Beneficiary | ||||
| Total distributions paid to non-controlling interests | ||||
| Contributions from non-controlling interests | ||||
| VIE, Primary Beneficiary | ||||
| Total contributions from non-controlling interests | ||||
| Distributions to redeemable non-controlling interests | ||||
| VIE, Primary Beneficiary | ||||
| Total distributions to redeemable non-controlling interests | ||||
| Proceeds from issuance of Class A units of SPAC, net of underwriting and offering costs | ||||
| Total proceeds from issuance of Class A units of SPAC, net of underwriting and offering costs | ||||
| Investments, at fair value | ||||
| Other assets | ||||
| Debt, at fair value | ||||
| Notes payable | ||||
| Other liabilities | ||||
| Non-controlling interest | ||||
| Equity | ||||
| Deferred tax assets | ||||
| Due to affiliates | ||||
| Additional paid in capital | ||||
| Non-Controlling Interest in Apollo Operating Group | ||||
| Issuance of Mandatory Convertible Preferred Stock, net of issuance costs | ||||
| Deposits on investment-type policies and contracts | ||||
| Withdrawals on investment-type policies and contracts | ||||
| Subsidiary issuance of equity interests to non-controlling interests | ||||
| Net change in cash collateral posted for derivative transactions and securities to repurchase | ||||
| Other financing activities, net | ||||
| Net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents | ||||
| Net increase (decrease) in cash and cash equivalents, restricted cash and cash held at consolidated variable interest entities | ||||
| Cash and cash equivalents, restricted cash and cash equivalents, and cash and cash equivalents held at consolidated variable interest entities, beginning of period | ||||
| Cash and cash equivalents, restricted cash and cash equivalents, and cash and cash equivalents held at consolidated variable interest entities, end of period | ||||
| Supplemental Disclosure of Cash Flow Information | ||||
| Cash paid for taxes | ||||
| Cash paid for interest | ||||
| Non-cash transactions | ||||
| Contributions to principal investments | ||||
| Distributions from principal investments | ||||
| Acquisition of goodwill and intangibles | ||||
| Purchase of investments | ||||
| Investments received from settlements on reinsurance agreements | ||||
| Investments received at inception of reinsurance agreements | ||||
| Investments received from pension group annuity premiums | ||||
| Reduction in investments relating to recapture of reinsurance agreement | ||||
| Assets contributed to consolidated VIEs | ||||
| Investments exchanged with third-party cedants | ||||
| Capital increases related to equity-based compensation | ||||
| Purchase of limited partnership interests | ||||
| Issuance of warrants | ||||
| Asset Management | ||||
| Total issuance of warrants | ||||
| Issuance of restricted shares | ||||
| Issuance of common stock related to equity transactions | ||||
| Subsidiary issuance of equity interest | ||||
| Issuance of common stock to donor-advise fund | ||||
| Deposits on investment-type policies and contracts through reinsurance agreements, net assumed (ceded) | ||||
| Withdrawals on investment-type policies and contracts through reinsurance agreements, net assumed (ceded) | ||||
| Distribution of investments to non-controlling interests of consolidated VIEs | ||||
| Borrowings of VIEs settled with investments | ||||
| Proceeds from sale of investments | ||||
| Proceeds from maturities of U.S. Treasury Securities - Asset Management | ||||
| Reconciliation of cash and cash equivalents, restricted cash and cash equivalents, and cash and cash equivalents held at consolidated variable interest entities to the consolidated Statements of Financial Condition: | ||||
| Cash and cash equivalents | ||||
| VIE, Primary Beneficiary | ||||
| Consolidated Entity, Excluding VIE | ||||
| Restricted cash and cash equivalents | ||||
Loading...